J. Bradley Rivet, VP Marketing at ACURA PHARMACEUTICALS, INC (ACUR), bought 2,000 shares at $1.23 ($2K) on 2014-05-19, disclosed to the SEC on 2014-05-19.
Open-market purchase of $2k ACUR by VP Marketing. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.